Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dimethyl fumarate induces necroptosis in colon cancer cells through glutathione depletion/ROS increase/MAPKs activation pathway.
Timing of birth and risk of multiple sclerosis: population based study.
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
Avonex drug warning letter, severe hypatic injury
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
[Prevalence of multiple sclerosis in the Region of Murcia].
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
CHMP issues positive opinion for TECFIDERA™ (dimethyl fumarate) as a first-line treatment for multiple sclerosis in the European Union
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Genetic analysis of aquaporin-4 in neuromyelitis optica.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro.
AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
[Neurophysiology in Guillain-Barré syndrome].
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Novantrone
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.

Pages